Skip to main content
. 2006 Jan 10;94(1):128–135. doi: 10.1038/sj.bjc.6602924

Table 2. Frequency of Ep-CAM overexpression in major human cancers.

    Ep-CAM expression
Tumour entity n Negative (%) Weak/ moderate (%) Strong (%)
All 3360 5.9 11.6 82.5
         
Colon        
 Adenocarcinoma NOS 1086 0.3 1.7 98.0
 Medullary carcinoma 5 20.0 0 80.0
 Mucinous carcinoma 88 0 4.5 95.5
 Signet ring cell carcinoma 4 0 0 100.0
 Other types 3 0 0 100.0
         
Stomach        
 Stomach carcinoma 473 2.5 6.8 90.7
         
Lung        
 Adenocarcinoma NOS 317 5.3 13.9 80.8
 Adenosquamous carcinoma 11 45.4 18.2 36.4
 Bronchioloalveolar carcinoma 60 3.3 21.7 75.0
 Large cell carcinoma 224 15.1 17.9 67.0
 Neuroendocrine carcinoma 56 16.1 19.6 64.3
 Squamous cell carcinoma 619 17.3 29.1 53.6
         
Prostate        
 Prostate carcinoma 414 1.9 10.9 87.2